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EXECUTIVE SUMMARY
This report details issues of misuse of pre-
scribed medications in South Gloucester-
shire. It looks into the origins of such issues 
from the United States, and how it has 
become an emerging trend in the United 
Kingdom, and in South Gloucestershire in 
particular. It also considers local challeng-
es as well as recommendations to address 
them.
Predominantly the issues around misuse of 
prescribed medications are related to pa-
tients taking doses above prescribed lev-
els, and non-directed use of the prescribed 
medication by individuals for whom they 
have not been prescribed. These may lead 
to tolerance and physical dependence. 
Opiates (such as codeine), central nervous 
system depressants (such as benzodiaz-
epines), antidepressants, antihistamines, 
and stimulants are typical medications that 
are often abused by patients.
The issues around prescribed medica-
tions should be addressed by the South 
Gloucestershire Drug & Alcohol Action 
Team (DAAT) at the earliest opportunity. An 
early involvement will help the local area to 
provide appropriate treatment interventions 
for those who are in need and champion 
the movement at regional and national lev-
el. In doing so, various national strategies 
can be used to support the move towards 
addressing the misuse of prescribed med-
ications, such as the Government 2010 
Drug Strategy, ‘Reducing Demand, Re-
stricting Supply, Building Recovery: Sup-
porting People to Live a Drug-free Life’, 
Building Recovery in Communities 2011, 
Public Health England’s Commissioning 
Treatment for Dependence on Prescrip-
tion and Over-the-counter Medicines 2013 
and the Localism Act 2011. In addition, 
the 2014 Order (SI 2014/1106) came into 
effect on 10th June 2014, restricting the 
prescribing of tramadol by GPs following a 
spike of deaths linked to recreational use 
of the drug. 
The genealogical investigations of the 
movement towards curbing the misuse of 
prescribed medications can be traced from 
the United States, where drug overdoses 
are the second largest cause of premature 
deaths from unintentional injuries. Evidence 
suggests that there is an emerging trend 
of misuse of prescribed medications in the 
UK, albeit in a pernicious manner. This is 
demonstrated by the annual number of 
prescriptions per person in the UK, which 
has increased from 11.9 in 2001 to 18.3 
per person in 2011.  In addition, a national 
research by Nuffield Health found that GPs 
are 46 times more likely to prescribe med-
ication for depression and other mental ill-
nesses than other medically proven alter-
natives, such as social prescribing.  
The statistics on drug-related deaths from 
the Office for National Statistics (ONS) in 
England and Wales, collected between 
1993 and 2013, show that  anti-depres-
sants were the most frequently cited sub-
stance on the death certificate for drug-re-
lated deaths, regardless of whether they 
were used in conjunction with other sub-
stances or not. Furthermore, the number of 
drug-related deaths among males are tri-
ple that for women. The most drug-related 
deaths are recorded for men aged 30 – 39 
and women aged 50 – 69.
In South Gloucestershire, the percentage 
of clients in treatment citing use of prescrip-
tion or over-the-counter medication (no il-
licit use declared by the patients) has been 
on an increasing trend since 2010; with 
benzodiazepines and prescribed opioid 
usage increasing yearly. It is also observed 
that the rate in South Gloucestershire is the 
highest among other local authorities in the 
South West region, and six times higher 
than the South West average. On the other 
hand, the percentage of clients citing use 
of prescription or over-the-counter drugs 
(with illicit use) is decreasing, and is lower 
than the South West average. According 
to the service users’ and carers’ voice, the 
concerns are around misuse of prescribed 
medications as a ‘quick fix’ for a long peri-
od of time.
There are four local challenges that have 
been identified in the prescribed medica-
tions, namely supporting the GPs with bet-
ter prescribing practices, identifiable links 
between misuse of prescribed medication 
and social deprivations, availability of data 
and intelligence, and connection with the 
other health services. 
To address these challenges, it has been 
proposed that a Specialist Service in Prima-
ry Care is vital, to support and advise GPs 
to provide treatment, to recognise when 
a patient needs more specialist care, and 
to support patients who cannot be treat-
ed in standard primary care settings. It is 
also anticipated that such a service will be 
the first one in England and Wales in cham-
pioning the awareness of, and movement 
towards addressing prescription medicine 
misuse. In addition, the service can pro-
vide a series of training sessions for GPs 
to address the issues, help patients to initi-
ate behaviour change to address their ad-
diction, conduct publicity campaigns, refer 
patients into treatment, and address issues 
surrounding online pharmacies.
Support for the GPs can also be strength-
ened by help from a trained pharmacist, 
where each GP surgery would have a 
trained surgery pharmacist to work with 
the GPs through formulation and operation 
of patient programmes. Linking with Men-
tal Health and Physical Activity Services is 
also desirable, to address co-morbid men-
tal health problems among patients and to 
provide some forms of social prescribing, 
particularly through physical activities, and 
ecotherapy activities.
It is anticipated that local data will be col-
lected, which will enable South Gloucester-
shire to become a regional and national in-
formation hub for the misuse of prescribed 
medications. This will assist with local intel-
ligence, coordinate future operational and 
strategic delivery, and facilitate communi-
cation and information sharing processes 
with partner organisations such as Public 
Health England (PHE), Avon & Somerset 
Constabulary, service user groups, GP 
practices, Clinical Commissioning Group 
(CCG), Mental Health services and Care 
Quality Commission (CQC).
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INTRODUCTION
What is the Misuse of Prescribed 
Medications All About?
What are the dangers of Prescribed Medications?
What are the Medications that Tend to Get Abused?
The concern surrounding misuse of prescribed medications is a rela-
tively recent phenomenon. It takes into account issues relating to taking 
doses above prescribed levels and non-directed use of the prescribed 
medication by individuals for whom they have not been prescribed. 
It is possible that this may lead to addiction if the process of prescribing 
by the General Practitioners (GPs), along with improper use of medicine 
among patients, are not addressed. ‘Addiction’ in this context refers to 
a primary, chronic, neurobiological disease, with genetic, psychosocial, 
and environmental factors influencing its development and manifesta-
tions.1 It is characterised by behaviours that include impaired control 
over drug use, compulsive use, continued use despite harm, and crav-
ing, which can lead to physical dependence2 and tolerance.3 The prescription medicines, if not being used as directed, may cause the following con-
sequences, depending on the type and dose of the drugs:
Short-term effects
• Sedation
• Lack of bodily co-ordination
• Altered states of consciousness
• Gastrointestinal issues such as nausea and diarrhoea
• Changes in blood pressure
• Changes in appetite
• Interactions with other substances such as drug and alcohol
Long-term effects
• Constipation
• Depressed respiration 
• Symptoms associated with withdrawal, including anxiety, depression, seizures, trem-
or and insomnia
• Tolerance and dependence
• Physical damage to the digestive system, liver and kidneys
Predominantly, the following prescription medicines tend to be abused by 
patients:
• Opiates, such as codeine, which are often prescribed to treat pain.
• Central nervous system depressants, such as benzodiazepines (diaz-
epam and tempazepam) and z-drugs to treat anxiety and sleep disor-
ders.
• Antidepressants, such as citalopram and mirtazapine.
• Antihistamines, such as chlorphenamine.
• Stimulants, such as dexamphetamine, to treat Attention Deficit Hyper-
activity Disorder (ADHD) or slimming. 
It has been observed by the All Party 
Parliamentary Group on Drug Misuse 
Inquiry that the prescription of opi-
oids for the relief of pain has increased 
steadily over the past decade, along 
with a wide variety of choices available 
to prescribers. However, the safety and 
efficacy of opioids remain unknown in the 
long term, particularly regarding the propen-
sity of opioids to cause problems of tolerance, 
dependence, and addiction, since therapy is of-
ten continued over months or years.4   
In addition, according to Battle Against Tranquilisers, 
Gabapentin and Pregabalin seem to be among the recent 
most popular newly prescribed drugs.5
1American Academy of Pain Medicine, ‘The Use of Opioids for the Treatment of Pain’, the American Pain Society and the American 
Academy of Pain Medicine (2001).
2A state of adaptation that is manifested by a drug class specific withdrawal syndrome that can be produced by abrupt cessation, rapid 
dose reduction, decreasing blood level of the drug, and/or administration of an antagonist. It is also known as ‘iatrogenic addiction’, 
which is a feeling of not being able to do without a drug and a desperate need to obtain and consume the drug to alleviate feelings that 
arise from not having it.  
3A state of adaptation in which exposure to a drug induces changes that result in a diminution of one or more of the drug’s effects over 
time.
4Stannard, C., ‘All Party Parliamentary Group on Drug Misuse Inquiry: Response on behalf of the British Pain Society - Risk of Addic-
tion to Opioids Prescribed for Pain Relief’ (2007), available at: http://www.britishpainsociety.org/APPG_report.pdf (last accessed: 3rd 
October 2014).
5Battle Against Tranquilisers’ Submission to the British Medical Association’s Call for Evidence on Involuntary Dependence to Prescrip-
tion Medications (2014).
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GOVERNING 
FRAMEWORK
Why Should the Issues on Misuse of Prescribed 
Medications be Addressed?
The issues on prescribed medications should be addressed by the 
South Gloucestershire Drug & Alcohol Action Team (DAAT) at the 
earliest opportunity. Despite the fact that the issues are consid-
ered as a slow burning problem at present, an early involve-
ment will help the local area to provide appropriate treatment 
interventions for those who are in need and champion the 
movement at the regional and national level.
In order to tackle the issues surrounding misuse of pre-
scribed medications, the following legal and regulatory 
framework can be used to enable the South Gloucester-
shire Drug & Alcohol Action Team (DAAT) to tackle the is-
sue:
• The Government 2010 Drug Strategy, ‘Reducing De-
mand, Restricting Supply, Building Recovery: Support-
ing People to Live a Drug-free Life’, highlights the need 
to respond to emerging drug threats and tackle drug de-
pendence.6 In particular, the strategy makes a reference to, 
‘dependence on all drugs, including prescription medicines’ 
and ‘local responses to drug misuse and dependence are also 
expected to cover dependence and other problems with medi-
cines.’ 
• Building Recovery in Communities 2011 enshrines the value of working 
with people who wish to take proactive steps in tackling their dependency 
on substance misuse, and offers an exit strategy through recovery.7
• Public Health England’s Commissioning Treatment for Dependence on Prescription 
and Over-the-counter Medicines 2013 recommends that a specialist response be 
commissioned as part of the drug and alcohol misuse treatment system, with support 
from the primary care in providing an enhanced service, and a dedicated provider 
within the integrated drug and alcohol treatment services.8
• Using this model as a framework, primary care practices will be expected to respond 
to the emerging problem of addiction to medicines as part of their regular patient 
care, within the terms of the General Medical Services (GMS) contract, with assis-
tance from a specialist service in tackling the misuse of prescribed medications.
• The 2014 Order (SI 2014/1106) which went into effect on 10th June 
2014, restricts prescribing of tramadol by GPs; it has been re-
classified as a class C drug, following a spike of deaths 
linked to recreational use of the drug. In practice, this 
will mean that GPs must provide written prescrip-
tions for both tramadol and temazepam, and 
will only be able to prescribe a month’s sup-
ply of the drugs at a time.
• Localism Act 2011 – This is an 
Act that provides freedom to shape 
the treatment in line with the Lo-
calism agenda, where the working 
model is based on the experience 
and understanding of local evi-
dence, and is appropriate to the 
context and population of South 
Gloucestershire.
6HM Government, ‘Drug Strategy 2010: Reducing Demand, Restricting Supply, Building Recovery: 
Supporting People to Live a Drug Free Live’ (2010).
7National Treatment Agency for Substance Misuse (NTA), ‘Building Recovery in Communities: A 
Summary of the Responses to the Consultation’ (2012).
8Public Health England, ‘Commissioning Treatment for Dependence on Prescription and Over-the-Counter Medicines: A Guide for NHS 
and Local Authority Commissioners’ (2013), available at: http://www.nta.nhs.uk/uploads/pheatmcommissioningguide.pdf (last ac-
cessed: 3rd October 2014).
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PREVALENCE 
OF PRESCRIBED 
MEDICATIONS MISUSE
Where Do These Issues Surrounding the Misuse of 
Prescribed Medications Originate From?
Are the Issues in Prescribed 
Medications Prevalent in the UK?
The genealogical investigations of the movement towards curbing the misuse of pre-
scribed medications are traced from the United States, where drug overdoses are the 
second largest cause of premature deaths from unintentional injuries. The latest available 
statistics in 2010 revealed that, in the US:
• There were 22,134 (58%) out of 38,329 drug overdose deaths attributed to prescrip-
tion medicines.9
• 1.5 million emergency admissions to hospitals each year are due to abuse of pre-
scribed medications.10
• 16 million Americans, aged 12 and above, were estimated to have used at least one 
type of prescription drug for non-medical reasons in the previous year.
• Pain killers, predominantly opiates, are the most commonly abused prescription drugs 
with 5.5 million US residents using them on a monthly basis, followed by tranquilisers 
(2.6m) and stimulants (1.1m).
In addition, some high profile celebrities, such as Michael Jackson (2009), Heath Ledger 
(2008), and Kurt Cobain (1994) heightened publicity on the misuse of prescription drugs 
in the past decades.
Evidence suggests that there is an emerg-
ing trend of misuse of prescribed medica-
tions in the UK, albeit in a pernicious man-
ner. 
At the national level, the annual number of 
prescriptions per person in the population 
has increased from 11.9 in 2001 to 18.3 
per person in 2011.11
Interestingly, an estimated 20% to 50% of 
all over-65s are being prescribed at least 
one anti-cholinergic drug, and while the 
effects of some are small, their cumulative 
effects may cause significant mental dete-
rioration in older people who already have 
some cognitive problems.12 Four out of five 
people over 75 years take a prescription 
medicine and 36% are taking four or more 
drugs. It has also been estimated by the 
same research that many drugs used to-
gether can cause problems and that ad-
verse reactions to medicines are implicated 
in 5-17% of hospital admissions.13 
In addition, it has been observed that GPs 
are 46 times more likely to prescribe med-
ication for depression and other mental ill-
nesses instead of other medically proven 
alternatives, such as social prescribing.14 
The same study looked into the behaviour 
of 2000 patients, where 44% experienced 
anxiety symptoms regularly; up 33% since 
the recession hit the UK in 2008.15 The re-
search also suggests the number of people 
experiencing low moods, an early indicator 
of depression, has also increased, jumping 
from 31% to 39%.16
The latest statistics on drug-related deaths from the Office for National Statistics (ONS), 
in England and Wales, between 1993 and 2013 depict the following trends:17
• Anti-depressants were the most frequently cited substance on the death certificate 
for drug-related deaths, regardless of whether they were used in conjunction with 
other substances or not. 
• Drug-related deaths among males are triple that related to women, particularly in 
2013.
• Men aged 30 – 39 recorded the most deaths that were drug-related, followed by 20 
– 29. The deaths among men tend to decrease with age.
• Women aged 50 – 69 recorded most the drug-related deaths, followed by those aged 
40 – 49. Compared to men, drug-related deaths among women tend to increase with 
age.
The findings above are indicative of the emerging trend of misuse of prescribed medica-
tions, which lead to death, in England and Wales. Figures 1 to 5 on the pages overleaf 
show charts depicting the trends above.
9Jones, C. M. et al, ‘Pharmaceutical Overdose Deaths, United States, 2010’ [2013] 309(7) Journal of the American Medical Association 
657.
10Ibid.
11NHS Information Centre (2012) Prescriptions Dispensed in the Community: England, Statistics for 2001 to 2011.
12Ibid
13N.11, supra.
14Nuffield Health, ‘Prescribing Exercise Key to Defusing ‘Ticking Mental Health Time Bomb’, available at: http://www.nuffieldhealth.com/
fitness-and-wellbeing/news/prescribing-exercise-key-to-defusing-ticking-mental-health-time-bomb (accessed: 14th November 2014).
15N.11, supra.
16N.11, supra.
17Office for National Statistics, ‘Deaths Related to Drug Poisoning, England and Wales 2013’ (2014), available at: http://www.ons.gov.
uk/ons/publications/re-reference-tables.html?edition=tcm%3A77-375474 (last accessed: 3rd October 2014).
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Figure 1: Number of Drug-related Deaths in England and Wales, With Substances Mentioned on the Death Certificate, 1993 - 2013
Figure 2: Number of Drug-related Deaths in England and Wales, Where Selected Substances Mentioned Without Other Drugs, 1993 - 2013
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Figure 3: Number of Deaths from Drug-related Poisoning, by Gender, 1993 - 2013
Figure 4: Number of Deaths from Drug-related Poisoning in England and Wales, Male by Age, 1993 - 2013
16 17
Figure 5: Number of Deaths from Drug-related Poisoning in England and Wales, Female by Age, 1993 - 2013
What is the Local Picture on the Misuse 
of Prescribed Medications?
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Given the ‘silent’ and ‘slow burning’ nature associated with the misuse of prescription 
drugs and the nature of some substances, it is difficult to accurately estimate the scale 
of the problem in South Gloucestershire. However, the overview of the drug treatment 
provision and access to the local treatment system, through the National Drug Treatment 
Monitoring System (NDTMS) show that, in South Gloucestershire:
• The percentage of clients in treatment citing prescription or over-the-counter use (no 
illicit use declared by the patients) has been on an increasing trend since 2010. It is 
also observed that the rate in South Gloucestershire is the highest among other local 
authorities in the South West region, and six times higher than the South West aver-
age.
• On the other hand, the percentage of clients citing prescription or over-the-counter 
drugs (with illicit use), is decreasing, and lower than the South West average.
The findings above are depicted in Figures 6 and 7 overleaf.
Using these two premises, it can be inferred that misuse of prescribed medications, with 
no illicit use, is prevalent in South Gloucestershire compared to its South West counter-
parts.18
In addition, the following trends have been observed, based on figures 8 – 13:
• For those clients who did not cite illicit drug use, the misuse of benzodiazepines and 
prescribed opioid usage have increased on a yearly basis. 
• For those clients who cited illicit drug use, the misuse of prescribed opioids and pre-
scribed drugs has increased on a yearly basis.19
It must be noted that the NDTMS data only covers those seeking specialist treatment. 
The current data capture mechanisms do not make specific references to the misuse 
of prescribed medications. Therefore the intelligence of those who do not approach 
treatment services for misuse of prescribed medications, and those who are developing 
problems with medicines at an early stage, are not apparent. 
In this context, it can be suggested that there may be gaps within the local treatment 
system and unmet needs in dealing with these cohorts of service users in South Glouces-
tershire.
WHAT IS THE LOCAL 
PICTURE ON THE 
MISUSE OF PRESCRIBED 
MEDICATIONS?
18 The NDTMS data also does not make a distinction between ‘prescribed medications’ and ‘over-the counter medications’.
19This should be caveated by the fact that South Gloucestershire has a service that specialises in benzodiazepine addiction (Battle 
Against Tranquilisers), which may have increased the reporting.
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Figure 6: Percentage of Clients Citing Prescription or Over-the-Counter Drugs (No Illicit Use) 2010 - 2013
Figure 7: Percentage of Clients Citing Prescription or Over-the-Counter Drugs (Illicit Use) 2010 – 2013
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Service Users Citing Prescription or OTC in South Gloucestershire (No Illicit Use)
Service Users Citing Prescription or OTC in South Gloucetershire (Illicit Use)
Figures 8, 9, and 10: Drug of Choice (No Illicit Use) 2010/2011 – 2012/2013
Figures 11, 12, and 13: Drug of Choice (Illicit Use) 2010/2011 – 2012/2013
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SERVICE USERS’ 
POINT OF VIEW
What are the Views of Service Users?
The following quotes were taken from the Rolling Comments, which is a ser-
vice users’ feedback forum, on issues concerning abuse of prescribed medications, 
from the perspectives of a service user, a carer, and a service provider, between April 
2013 and August 2014. Thematically, the concerns are around misuse of prescribed 
medications as a quick fix for a long period of time (by both a service user and a carer), 
and issues about service users not being involved in the prescribing process (by a ser-
vice provider):
‘I can remember coming downstairs one morning to find T 
with a handful of white pills. He quickly put them in his mouth 
and turned away from me. I asked what they were and he 
replied, ‘They are for my anxiety, you know that.’
I didn’t know. I admit that on one occasion when he was out 
I found his little white pills to check what they were. The label 
was for Flurazepam from the Benzodiazepine group. What’s 
that I thought? I had no idea. I knew that he had been pre-
scribed a modern ant-depressant by his GP but this was not 
the medication. So, good old Google informed me all about 
it and the dangers of staying on this medication for long. It is 
used as a pre-med before an operation and at times up to 2 
weeks with a GP prescription.
I was worried and needed more information. When speaking 
to one of his daughters I casually mention it and she informed 
me that it was the drug known as Valium and it had been 
prescribed it when he was 18 years old for a shoulder injury. 
That was 46 years ago.’ 
- AS, Carer, August 2014
‘Medication is a catch 22 for P as he 
feels he would need to take them for 
as long as possible with no way out 
and that safety net that could keep him 
on [subutex] as long as he has to with-
out the thought of withdrawing or being sick 
which he quotes, ‘The worse feeling ever.’
The fear of being sick reminds him every time when 
he wakes up and blames that first drink on the first day out 
of treatment. The reason I asked to speak to P was the high-
light around pills and [medications] and the control it has over 
people who abuse them to get the satisfaction it [does not]! 
[It gives] you towards the end! [Again, it highlights] the seri-
ousness around tablets and medication that only fixes people 
temporarily’ 
- D, Service user, June 2014
‘Another issue which I have often spoken with service users 
about is whether medication can be taken home or needs 
to be taken in the pharmacy.  The final decision around this 
is made by the GP who signs the prescription.  However, at 
DHI we do try to work with GP’s, with the hope that as far as 
possible, decisions around prescriptions are fair and consis-
tent, whilst also being safe. I am always happy to hear from 
service users who don’t agree with any decisions around their 
prescription. The aim of a Manager looking again at prescrib-
ing decisions would be to make sure we have got the right 
balance of listening to the view of the person who has the 
[prescription], while making sure that we are working in a safe 
way’ 
– Treatment Service Manager, DHI, June 2014
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LOCAL CHALLENGES
What are the Local Challenges on the Misuse 
of Prescribed Medications?
Assisting GPs with Better Prescribing Practices
There are four local challenges that have been identified in the prescribed medications, 
namely assisting the GPs with better prescribing practices, identifiable links between 
misuse of prescribed medication and social deprivations, availability of data and intelli-
gence, and connection with the other health services. 
Clinicians should be alert for behaviours suggestive of aberrant drug use. Most cases 
refer to problematic behaviours in patients prescribed opioids for pain. The risk factors 
below may indicate inadequate treatment of pain, physical dependence, or an attempt 
by the patient to relieve distressing symptoms other than pain:20
• Simulating withdrawal symptoms when further supplies of the drug are refused or the 
dose reduced.
• Simulating an exacerbation of the underlying medical condition if a prescription is 
refused or dose reduced.
• Giving a history of inefficacy or poor tolerance of alternative medicines without misuse 
potential, or non-pharmacological treatment options.
• Asking for prescriptions to be re-issued because of repeated unsubstantiated ep-
isodes of prescription loss; claiming that supplies have run out early; altering the 
quantity or identity of drugs to be supplied on a prescription; approaching a second 
doctor in order to obtain supplies if the first one refuses.
• Stealing medication or prescriptions; buying supplies of medication from illicit domes-
tic sources, from abroad, or via the Internet.
• Making threats, or offering bribes, to prescribers or those supplying medication. 
In managing the abovementioned problems, the following approaches have been advo-
cated:21
• The propensity for patients to use opioids problematically should be discussed be-
fore starting therapy. If concerns are noted these need to be discussed openly and 
non-judgmentally with the patient. The rationale for the concerns should be explained 
and the patient should be reassured that safe provision of analgesia remains the pri-
mary goal of therapy. The plan for evaluation of therapy may need to be modified. 
Frequency of assessments should be increased and drugs should be prescribed in 
small quantities. 
• Problems should be discussed with other healthcare professionals involved in the 
patients’ management.  It may be helpful to ask the patient to be reviewed by a spe-
cialist in addiction medicine.  
• All discussions with the patient should be carefully documented and the patient should 
be given a copy of the written record of the discussion.  
• Individuals with a history of substance misuse are at risk of developing problems 
when prescribed opioids for pain relief, however there are a number of reasons why 
substance misusers have greater than usual pain management needs. If opioids are 
the most appropriate therapy they may be prescribed for these patients as part of a 
multidisciplinary treatment plan. Comprehensive assessment of both pain and addic-
tion is mandatory and therapy should be closely monitored by professionals in both 
pain management and addiction medicine.
Autonomy and Trust
GPs in the UK enjoy a great deal of autonomy. With autonomy comes the notion of trust 
to make complex clinical judgments. It would therefore be desirable for GPs to keep up-
to-date with the latest information on prescription drugs. 
Incentivisations
A major impediment to reducing polypharmacy is that the payment system for GPs ef-
fectively rewards it.22  Under changes introduced by the Department of Health in 2004, 
GPs’ remuneration is linked to managing specified medical conditions, including cardio-
vascular disease, diabetes, high blood pressure, asthma, obesity, and smoking. 
In light of this, there needs to be a change in paradigm by the GPs to ensure their buy-in 
into responsible prescribing practices.
20N.4, supra.
21N.4, supra.
22McCarthy, M., ‘The Patient Paradox: Why Sexed-up Medicine is Bad for Your Health’, Pinter & Martin (2012).
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Prevailing Patients’ Informed Consent
Patients’ consent is central to dichotomy of all treatment interventions. In order for the 
patients to give an informed consent, GPs need to provide sufficient information to un-
derstand the potential therapeutic benefits and harms of the prescribed medications, 
and available alternative treatments. 
In addition, patients can be empowered to inform the GPs about their misuse of medi-
cations at the earliest opportunity, and can be signposted into the appropriate treatment 
programme
If the patients regularly take more than one prescription medicine, or take medicines for 
a long-term illness, they can be signposted to their local pharmacist for a Medicines Use 
Review, in which they can discuss the issues and concerns relating to their medicines.23
23Medicines and Healthcare Products Regulatory Agency, ‘Medicines Use Review: Understand Your Medicines’ (2005), available at:  
http://www.mhra.gov.uk/home/groups/pla/documents/websiteresources/con2023072.pdf (last accessed: 3rd October 2014).
24National Treatment Agency, ‘Addiction to Medicine – An Investigation Into the Configuration and Commissioning of Treatment Services 
to Support Those Who Develop Problems with Prescription-only or Over-the-counter Medicine’ (2011), available at:
http://www.nta.nhs.uk/uploads/addictiontomedicinesmay2011a.pdf (last accessed: 3rd October 2014).
25Reed, K. et al, ‘The Changing Use of Prescribed Benzodiazepines and Z-drugs and of Over-the-counter Codeine-containing products 
in England: A Structured Review of Published English and International Evidence and Available Data to Inform Consideration of the 
Extent of Dependence and Harm’ (May 2011).
26Nuffield Health, ‘Prescribing Exercise Key to Defusing ‘Ticking Mental Health Time Bomb’ (2013):
http://www.nuffieldhealth.com/fitness-and-wellbeing/news/prescribing-exercise-key-to-defusing-ticking-mental-health-time-bomb
(last accessed: 3rd October 2014).
Correlations with Social Deprivation
Availability of Data and Intelligence
Links with Other Health Services
Social deprivation has been shown to be the major determinant of prescribing volume, 
with more deprived areas reporting higher levels of prescribing.24 This could perhaps 
provide a partial explanation for the distribution of the prevalence of prescribing seen 
within the regional data for these drugs. This notion may also provide an explanation for 
the similar pattern of prescribing prevalence for opioid analgesics.
There are many, if not all, publications that call for better data collection for monitoring 
purposes. 
Since the NDTMS data returns only deal with a minimum amount of data collection as 
predicated by the NDTMS core datasets, it is anticipated that a local data collection may 
assist in forming a better picture of prescribed medication abuse in South Gloucester-
shire. 
This can be done by collecting the data in terms of the frequency and complexity of the 
prescribed medication abuse by the patients.
The addiction of prescribed medications does not only exist in the substance misuse 
realm; it transcends across other interface services. Often, patients are vulnerable, par-
ticularly those with co-morbid mental health problems. 
In this context, linking with mental health services will be beneficial in providing an 
integrated response to the patients’ addiction. An example of cross-provision of treat-
ment includes availability of psychological treatments as alternatives to prescribed med-
icines, including through the Increasing Access to Psychological Therapies (IAPT) pro-
gramme. 25
In addition, it is an opportunity to provide some forms of social prescribing, particularly 
through physical activities and ecotherapy activities. A study by Nuffield Health in 2013 
showed that, 1% of those who visited their GP were told to exercise to alleviate low 
moods or anxiety, compared with 46% who were prescribed anti-depressants.26 The 
push for less reliance on anti-depressants is supported by those surveyed, with 4% say-
ing they would prefer to be prescribed medication over exercise, if given the choice. The 
study also showed 76% thought exercise lifted their mood and 72% were aware it was 
clinically proven to manage moderate anxiety or low moods.
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RECOMMENDATIONS
What Can be Done to Address the Misuse of 
Prescribed Medications in South Gloucestershire?
Provision of Specialist Service in Primary Care
The following recommendations are proposed, to address the prevalence and challeng-
es identified around the misuse of prescribed medications in South Gloucestershire:
Specialist responses can be piloted in selected primary care settings as a starting point, 
to support and advise GPs to provide treatment, to recognise when a patient needs 
more specialist care, and to support patients who cannot be treated in standard primary 
care settings. It is also anticipated that such a service will be the first one in England and 
Wales in championing the awareness and movement towards addressing prescription 
medicine misuse. 
The specialist service can bring the following benefits to the local primary care and the 
substance misuse treatment system:
• The knowledge and expertise on better prescribing practices, particularly on those 
patients who may have been using medicines for many years and may need long-term 
withdrawal and extensive support, including for co-occurring and emerging mental 
and physical health problems
• Effective promulgation of good practice recommendations in relation to opioid pre-
scribing. All prescribers (medical and non-medical) should be aware of important ad-
diction considerations when prescribing opioids for pain relief.
• Familiarity with or preference for the drug. Some doctors prefer some drugs to others, 
based on their experience of what works with other patients, or what new research 
tells them. 
Appropriate clinical governance mechanisms will need to be in place to ensure safe and 
effective prescribing of medicines liable to dependence, and for the treatment of depen-
dence, and to prevent and detect diversion of prescription medicines by patients.
The following do not count as a full clinical medication review, but may be useful as part 
of the medication review process, which is also in line with a Standard Operating Proce-
dure (SOP) for medication review:
• Technical check of the medication list or tidying up medication records by removing 
unrequested items from repeats or dose optimization. 
• Switching to a formulary item ‘linking’ medication to a ‘problem’.
• Re-authorising the repeat list or reviewing an individual medication or disease without 
reviewing all medication as above.
• Asking the patient ‘is everything else alright?’ at the end of a consultation.
Training for GPs
The specialist service can deliver training on diagnostic tools, methods for stopping 
treatment and information about alternative therapies or medicines. The service can also 
co-deliver the training with the GP Leads for drug and alcohol for South Gloucestershire 
under the Royal College of General Practitioners (RCGP) umbrella on an annual basis.
Empowering Patients to Initiate Behaviour Change
If patients are not comfortable returning to the GP who prescribed the medicine on 
which they have become dependent, the service can empower them by informing their 
right to see another GP or register with another practice. Patients, and sometimes their 
GPs, may be unaware that there is a problem with a prescription medicine. The spe-
cialist service in primary care practices can help to identify problems and link patients to 
appropriate treatment. 
In addition, the specialist service will have a role in signposting the patients into mutual 
aid to accelerate recovery.
Publicity
In ensuring that the patients and members of the public are aware of the problems that 
can arise with prescribed medicines, the following publicity strategies can be adopted 
by the specialist service:
• Ensure best use of technology in relation to the dissemination of information linked 
to misuse of prescribed medicines including social media, social networking sites, 
smartphone applications, texting, and radio campaigns.
• Work in conjunction with health services such as GP surgeries, pharmacies, hospi-
tals, and sexual health providers to ensure the effective dissemination of public health 
awareness messages linked to misuse of prescribed medications.
Issues Surrounding Online Pharmacies
It is also relatively easy to purchase benzodiazepines on the Internet.27 There  are  con-
siderable risks  in  buying  drugs  online  as  they  may  be  counterfeit  drugs  whose 
safety cannot be assured. It will be recommended that the publicity campaign be ex-
tended  publicising  the  potential risks  people  expose  themselves  to  when  they  buy 
from  fraudulent  online pharmacies.
27Ray. G., ‘All-Party Parliamentary Drugs Misuse Group - An Inquiry into Physical Dependence
and Addiction to Prescription and Over-the-Counter Medication’ (2007), available at: http://www.drugscope.org.uk/Resources/Drug-
scope/Documents/PDF/Appgotcreport.pdf (last accessed: 3rd October 2014).
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Referral into Structured Treatment
One of the advantages of having a specialist service, apart from articulating better pre-
scribing approaches to the GPs, is to ensure that patients receive appropriate support 
through the local structured treatment system. 
In addition, based on the Public Health England’s observation:
• Performance data from local services suggests that once a client is engaged with 
services, treatment seems to work well. 
• Low waiting times for access into dedicated services, suggesting that where these 
services exist, they are meeting the demand. 
• Individuals reporting problems with prescribed medications generally tend to engage 
with treatment for six months or more.
• A higher proportion of these individuals exit drug treatment services having complet-
ed treatment successfully than the wider drug treatment population.
Figure 14 below shows the rate of successful completions for these cohorts of clients:
Figure 14 above can be used as an indication that for those who did not cite illicit use, 
if they are referred into the local treatment system, the chances of increasing successful 
completions are higher.
Figure 14: Rate of Successful Completions for Clients with Prescribed Medications and 
Over-the-counter Misuse Against Average Treatment Population
Provision of Support by a Trained Pharmacist
Linking with Mental Health and Physical Activity Services
Data and Intelligence Gathering
Support for GPs can also be strengthened by support from a trained pharmacist. Each 
GP surgery should have a trained surgery pharmacist to work with the GPs through for-
mulation and operation of patient programmes.
Support by the surgery pharmacist should be on a regular fortnightly basis during the 
withdrawal programme, and for a minimum of six months after the completion. The 
support should involve a meeting at the surgery to make sure withdrawal symptoms are 
at acceptable levels, and if not, further reductions should be left until these symptoms 
subside. Particular care must be taken to assess any increased depression which may 
require appropriate treatment. Follow-up visits should continue monthly for an additional 
twelve months.
Linking with mental health services will be beneficial in providing an integrated response 
to the patients’ addiction. Examples of cross-provision of treatment include the availabil-
ity of psychological treatments as alternatives to prescribed medicines, including through 
the Increasing Access to Psychological Therapies (IAPT) programme.28
In addition, it is an opportunity to provide some forms of social prescribing, particularly 
through physical activities, and ecotherapy activities.
It is anticipated that the collected data will enable South Gloucestershire to become a 
regional and national information hub for the misuse of prescribed medications. This will 
assist with local intelligence, coordinate future operational and strategic delivery, and 
facilitate communication and information sharing processes with partner organisations 
such as Public Health England, Avon & Somerset Constabulary, service user groups, 
GP practices, Clinical Commissioning Group (CCG), and Mental Health services. The 
success of the interventions can be monitored through provision of the outputs and 
outcomes below:
28N.25, supra.
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Outputs
Data collection framework at the service level can be focused on gathering the epide-
miological data relating to the scale of the misuse of prescribed medications in South 
Gloucestershire. This will include collating the following information:
• Types of drugs used
• Usage with other substances
• Motivation of use
• Methods of consumption
• Methods of obtaining the substances
• Frequency of use
• Concurrent health-related and other behaviours
• Outcomes of use, such as acute harm, toxicity, or dependency
• Demographic patterns of the service users
• Collection of full postcodes of the service users to determine the prevalence of pre-
scribed medications abuse within certain wards, particularly in the neighbourhood 
priority areas
• Signposting to the community treatment services
• Service users’ satisfaction with the project
At the DAAT level, monitoring and responding to prescribing and purchasing patterns of 
primary care will be the first port of call for most patients dependent on prescription or 
OTC medicines. This can be done through obtaining the data from South Gloucester-
shire Clinical Commissioning Group (CCG) and the Care Quality Commission.29
Outcomes
The data collection exercise above will enable the DAAT to monitor the effectiveness of 
treatment intervention for those who are addicted to prescribed medications through the 
following outcome measures:
• Evidence of positive outcomes for service users, particularly on the recovery.
• Effective signposting into the treatment system and appropriate support services for 
those who require further interventions.
• Availability of support for parents and concerned others who are affected by the mis-
use of prescribed medication.
• Improved data collection and information sharing, to inform operational and strategic 
decision-making of the DAAT and its partner organisations.
• Increased public awareness and understanding of the community on prescribed 
medication misuse, associated harms and the availability of advice, information, and 
support.
• Increased GP confidence, to identify and respond to prescribed medication misuse 
on presentation.
• Formulation of consumer profiling to determine the level of prescribed medication 
misuse within South Gloucestershire and the wider health needs.
• Evidence positive outcomes for individuals and demonstrate good value for money.
29Price, C., ‘CQC to Publish Practices’ Antibiotic and Benzodiazepine Prescribing Data’ (2014), available at: http://www.pulseto-
day.co.uk/your-practice/practice-topics/regulation/cqc/cqc-to-publish-practices-antibiotic-and-benzodiazepine-prescribing-da-
ta/20008131.article#.VDbidvldV8F (last accessed: 7rd October 2014).
